Sales up, profits down
Q2 revenue and EBITDA diverged
Watch: Watch operating conversion
Home / Research / 20 Microns Limited
Sales up, profits down
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
Q2 revenue and EBITDA diverged
Watch: Watch operating conversion
EBITDA fell 12.9% year on year
Watch: Watch margin rebound
PAT fell more sharply than sales
Watch: Watch earnings quality
216 basis points lower year on year
Watch: Watch power and freight
20 Microns Limited (NSE: 20MICRONS) | Q2 and H1 FY2027 | Consolidated results | 20 November 2026
Decision dashboard — WATCH. Revenue returned to modest growth, but operating profit and net profit declined sharply. The central investment question is whether specialty-product mix, captive minerals and solar power can restore margins before a ₹100 crore investment programme increases the capital employed. This is a monitoring stance, not a price-target recommendation: the accepted earnings transcript and investor presentation do not provide a current share price or market-capitalisation input for a defensible valuation multiple.
| Consolidated metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue from operations | ₹238.16 crore | ₹230.78 crore | +3.2% |
| EBITDA | ₹27.73 crore | ₹31.85 crore | -12.9% |
| EBITDA margin | 11.6% | 13.8% | -216 basis points |
| Profit before tax | ₹19.20 crore | ₹23.46 crore | -18.1% |
| Profit after tax | ₹13.64 crore | ₹17.35 crore | -21.4% |
| Gross margin | 47.7% | 47.6% | +14 basis points |
The divergence is the story. Product mix helped protect gross margin, but power, fuel, freight and staffing costs reduced the operating conversion of revenue into EBITDA. The company estimates roughly ₹4.78 crore of identified energy and freight cost pressure, equivalent to about 200 basis points of consolidated EBITDA margin. These are management figures rather than an independently modelled adjustment. S1 S2
20 Microns develops engineered mineral inputs and functional additives used in paints, polymers, rubber, cables, inks and other industrial applications. Its argument for a better-quality business than commodity minerals is customer-specific formulation, long qualification cycles and more sophisticated surface treatment. Management says approvals for customised grades can take three to ten years, making approved suppliers harder to replace. This may create durable relationships, but it does not eliminate exposure to customer volumes, raw-material prices or freight.
The positive case depends on a higher specialty mix translating into sustained operating margins and cash returns, not simply on launching more grades. In Q2, consolidated sales rose 3.2% while EBITDA fell 12.9%. Until that divergence reverses, the margin recovery remains a hypothesis. The investment case becomes stronger if Q3 and Q4 show rising sales alongside better EBITDA conversion, lower working-capital absorption and evidence that new projects are commissioned on time.
Valuation must be tested against a contemporaneous share price, net debt and forward cash generation before assigning an entry level. The accepted documents support an operating assessment, not a reliable current P/E, EV/EBITDA or upside percentage. A low headline multiple would not itself compensate for structurally weaker margins; conversely, sustained margin recovery could support higher earnings even with modest sales growth. The appropriate stance is to watch for proof, not assume the company's long-run aspirations are already priced in. S1 S2
The consolidated Q2 revenue base of ₹238.16 crore compares with ₹230.78 crore a year earlier and ₹244.72 crore in Q1 FY27. The year-on-year improvement therefore coexists with a sequential revenue decline. Q2 EBITDA of ₹27.73 crore was lower than ₹31.85 crore a year ago and ₹35.87 crore in Q1. The 11.6% margin was 216 basis points below the previous year's quarter. Gross margin, by contrast, held at 47.7%, broadly matching 47.6% a year earlier. This points to operating expenses below gross profit as the immediate earnings pressure.
For H1 FY27, consolidated revenue reached ₹482.88 crore, compared with ₹477.95 crore in H1 FY26, growth of approximately 1.0%. EBITDA fell to ₹60.13 crore from ₹63.60 crore, and EBITDA margin declined to 12.5% from 13.3%. H1 PAT was ₹31.38 crore versus ₹34.22 crore, a decline of 8.3%. Gross margin improved to 48.3% from approximately 47.5%, or about 79 basis points. This combination reinforces the need to distinguish a better product mix from actual operating-profit expansion.
The finance-cost line offers a small offset: Q2 finance cost was ₹4.20 crore versus ₹4.45 crore a year earlier, and H1 finance cost was ₹8.11 crore versus ₹9.14 crore. The benefit was not large enough to offset EBITDA weakness. Management attributed much of the quarterly pressure to furnace oil, gas and freight. It cited furnace oil moving from approximately ₹42/kg to ₹56/kg, gas from ₹69/kg to ₹122/kg, and freight per tonne from ₹2,108 to ₹2,346. These figures are useful for testing whether relief in input costs reaches reported margins. S1 S2
20 Microns serves several distinct end markets. Its FY26 presentation attributes approximately 46% of revenue to paints and coatings, 26% to polymers, pipes and cables, 10% to rubber, 5% to paper, 4% to ceramics and 9% to other applications. These are FY26 mix figures, not a claim about Q2 FY27 segment revenue. The paints exposure is important: management said polymer, rubber and construction-chemical customers delivered double-digit growth in the quarter, while paints demand was subdued. Customer price increases do not necessarily translate into the same growth for a business-to-business ingredient supplier.
The portfolio includes industrial minerals, performance minerals and functional additives. Management describes more than 250 specialised additive grades and says functional additives contribute about one-quarter of revenue. The economic opportunity is to replace lower-value, price-per-tonne material with performance-specific formulations that command better pricing and retention. However, product approval may take years, and the margin benefit can be obscured by raw-material and logistics costs. A higher specialty revenue share should therefore be evaluated together with gross margin, EBITDA margin and cash returns.
The presentation describes a DSIR-recognised research centre in Vadodara with more than 35 scientists and engineers, as well as a customer base exceeding 1,000. Four products were commercialised in FY26. These capabilities support the pipeline but do not guarantee near-term revenue. Management discussed capacity expansion in calcium carbonate, engineered kaolins, talc and nano-related additives. The next proof point is commercial volumes and profitability from those grades, not just the number of introductions or customer trials. S1 S2
Chief Executive Atil Parikh presented the business as a specialty mineral solutions supplier rather than a basic mining company. He emphasised formulation-level customer relationships, product mix and a measured shift toward more engineered inputs. The strategic direction is coherent with the company's stated R&D and investment plans. Yet Q2 showed the distinction between strategy and results: gross margin remained stable, while operating margin contracted materially.
During the investor questions, management said that a targeted approximately 18% growth CAGR remained an ambition tied to projects and mineral reserves over the next two to three years, but it declined to provide a specific near-term revenue figure given uncertain markets and costs. This should be treated as an aspiration, not as guaranteed guidance. Management expected H2 to improve over H1, while acknowledging that near-term operating conditions were difficult to forecast.
The most concrete execution commitments are the 9 MW captive solar project, the start of production from acquired mines, and staged investment in higher-value mineral capacity. Each can be assessed independently. Delays to solar commissioning would postpone the proposed power savings. Delays in mine operations would defer supply-cost benefits. If new capacity arrives without sufficient customer orders, depreciation and financing costs could dilute returns. Investors should demand quarter-by-quarter delivery rather than relying on a distant margin target. S1 S2
Management described a ₹100 crore capital-expenditure programme spread over approximately 24 months. Roughly ₹30 crore had been deployed by the Q2 call, including approximately ₹12 crore for captive solar and ₹7 crore for two mining acquisitions. A further ₹17 crore of solar spending was anticipated in the following quarter, bringing the cumulative programme close to half of its planned size. The remaining investments are intended to expand specialty and value-added production capacity.
The captive solar project comprises 5.5 MW in Rajasthan and 3.5 MW in Gujarat, for 9 MW in total. Management estimated total solar investment of approximately ₹29 crore and said the system could meet about 40% of electricity needs. It estimated around ₹8 crore in annual EBITDA benefit at full operation. The transcript contains a timing ambiguity: opening remarks discuss Q4 FY27 commissioning and subsequent benefits, while a question-and-answer response refers to a full run-rate from FY29. Investors should use the actual commissioning date and reported savings to resolve this, rather than assume an immediate full-year uplift.
The company also discussed talc, quartz and feldspar mine assets in Andhra Pradesh and Rajasthan, with production targeted from December 2026. These projects are intended to reduce raw-material supply and cost volatility. The presentation cites net debt/equity around 0.16 times; that ratio does not by itself establish free-cash-flow strength. Funding through internal accruals and selective borrowing means operating cash generation, inventory normalisation, receivables and debt movement are crucial as the investment programme proceeds. A capital project that improves accounting EBITDA but absorbs disproportionate cash is not automatically value-creating. S1 S2
Bull condition: Product mix continues to improve, Q2's energy and freight inflation subsides, mines begin supplying inputs and solar projects are commissioned near schedule. Revenue grows faster than the low-single-digit Q2 pace, while EBITDA margin returns toward the company's historical 12–14% operating range. Cash conversion supports the investment programme without materially increasing financial risk. The bullish case requires evidence of all three: customer demand, margin recovery and disciplined capital spending.
Base condition: Sales grow modestly, but costs remain uneven through the next few quarters. Specialty-product gains protect gross margin, while freight and power limit EBITDA conversion. Capex proceeds in stages, with benefits arriving gradually. Under this outcome, earnings could improve from Q2 without immediately returning to earlier margins. A patient monitoring approach is more appropriate than assuming a rapid rebound.
Bear condition: Paint-sector demand remains weak, energy and freight costs stay elevated, customers resist price increases, or projects slip. New capacity adds depreciation and financing demands before incremental earnings arrive. The company may then face weaker operating cash flow and lower returns on capital despite an expanding specialty portfolio. Further margin compression from 11.6%, together with flat or falling revenue, would be a clear warning.
Key uncertainties include commodity and energy inflation, export logistics, mining approvals, customer qualification timing, competitive pricing and capital allocation. Management's long-run growth aspirations are particularly sensitive to execution and the external cost environment. No scenario here is a numerical share-price forecast; the accepted documents do not provide a defensible current market valuation input. S1 S2
Next-quarter financial test: Compare consolidated revenue against ₹238.16 crore and EBITDA against ₹27.73 crore, while watching the EBITDA margin relative to 11.6%. A recovery in revenue alone is insufficient if operating profit continues to fall. Also track gross margin against 47.7%; a decline would suggest that even the mix advantage is under pressure.
Cost test: Monitor reported furnace-oil, gas and freight trends, and whether the identified roughly ₹4.78 crore cost headwind reverses. The presentation's 48.3% H1 gross margin demonstrates that a better mix can coexist with lower EBITDA margin. Improved conversion from gross profit into EBITDA would be more persuasive evidence of recovery.
Project test: Verify the planned December 2026 mine production start and Q4 FY27 solar commissioning. Ask for actual generation, grid-power substitution and realised cost savings rather than treating the estimated ₹8 crore annual solar benefit as already earned. Monitor total capex deployed against the ₹100 crore plan and whether the specialty capacity ramp-up attracts customer orders.
Capital and governance test: Track inventory, receivables, operating cash flow, net debt and debt/equity as spending rises. The company indicated no current buyback plan in the Q2 call. Capital allocation should therefore be judged primarily by the returns and cash generation of the announced projects, not speculation about distributions.
Action: Maintain a WATCH stance until at least one subsequent quarter demonstrates better EBITDA conversion and tangible progress on project milestones. A stronger case would combine revenue acceleration, improving margin and cash conversion; a weaker case would show sustained operating pressure or material capex slippage. This framework is a disciplined way to update the thesis without pretending that an operating presentation alone determines an entry price.
Primary accepted sources: S1 — Q2/H1 FY27 earnings-call transcript, call 30 October 2026; filed 2 November 2026; S2 — Q2/H1 FY27 investor presentation, filed 30 October 2026. All figures and management comments above refer to the period ended 30 September 2026 unless explicitly stated otherwise.
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
https://nsearchives.nseindia.com/corporate/20MICRONS_30102026175738_BseNseConferenceCallOutcomeSept2026SignUpload.pdf
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.